POLARITYTE, INC. (PTE) News Headlines

▮ More

Date

Headline

10/7/2021 8:27:13 AM PolarityTE Says It Developed Strong Plan To Address Clinical Hold On IND For SkinTE - Quick Facts

10/7/2021 8:05:44 AM PolarityTE Says Strongly Believe In Potential For SkinTE In Chronic Cutaneous Ulcers

9/2/2021 8:31:54 AM PolarityTE Appoints Richard Hague As CEO, Ryan Mathis As Chief Medical Officer - Quick Facts

9/2/2021 8:06:13 AM PolarityTE Names Richard Hague CEO; Elects David Seaburg To Board

8/24/2021 8:40:06 AM PolarityTE Says Study Proposed In IND Application For SkinTE Placed On Clinical Hold - Quick Facts

8/24/2021 8:10:10 AM PolarityTE Says Study Proposed In The IND Has Been Placed On Clinical Hold

8/12/2021 4:05:13 PM PolarityTE Inc. Q2 adjusted earnings Beat Estimates

8/12/2021 4:04:01 PM PolarityTE Q2 Loss/share $0.04 Vs. Loss $0.33 Year Ago

8/12/2021 3:00:11 PM PolarityTE Q2 21 Earnings Conference Call At 4:30 PM ET

7/28/2021 9:12:56 AM PolarityTE : SkinTE Meets Primary Endpoints In Final Analysis From Diabetic Foot Ulcer Trial

7/28/2021 8:06:11 AM PolarityTE Says SkinTE Met Primary And Secondary Endpoints In Final Analysis From Diabetic Foot Ulcer Trial

7/26/2021 8:52:06 AM PolarityTE Seeks Authorization To Commence SkinTE Trial On Chronic Cutaneous Ulcers

5/13/2021 4:12:27 PM EARNINGS SUMMARY: Details of PolarityTE Inc. Q1 Earnings Report

5/13/2021 4:10:18 PM PolarityTE Q1 Loss/share $0.24 Vs. Loss $0.39 Year Ago

5/10/2021 10:27:15 AM PolarityTE : Diabetic Foot Ulcer Trial Meets Primary And Secondary Endpoint

5/10/2021 8:15:59 AM PolarityTE Says Diabetic Foot Ulcer Trial Met Primary And Secondary Endpoint

3/30/2021 7:33:46 AM Polarity TE Reports Narrower Net Loss For FY20

3/30/2021 7:04:34 AM PolarityTE 2020 Net Loss $42.85 Mln Vs Net Loss $92.49 Mln Last Year

3/30/2021 7:00:17 AM PolarityTE Q4 20 Earnings Conference Call At 8:00 AM ET

3/1/2021 8:12:11 PM Pioneering Technology Corp. Q1 Net Loss $673,435 Vs Net Income $324,733 In Prior Year

Polarityte, Inc. (PTE)